Core Viewpoint - LabTech Holdings, a major shareholder of Beijing Laibotai Technology Co., Ltd., has signed a share transfer agreement to sell 4,145,454 shares at a price of 27.50 yuan per share to Qingdao Innovation Investment Co., Ltd., which will result in Qingdao Innovation becoming a shareholder with over 5% ownership in the company [2][4]. Group 1: Share Transfer Details - The share transfer involves 4,145,454 shares, representing 6.15% of the total shares of the company [2][5]. - The transfer price is set at 27.50 yuan per share [2][4]. - The transfer has received compliance confirmation from the Shanghai Stock Exchange and a securities transfer registration confirmation from China Securities Depository and Clearing Corporation [5][6]. Group 2: Post-Transfer Commitments - Qingdao Innovation Investment has committed not to reduce its holdings of the transferred shares for 12 months following the completion of the transfer [3][7]. - The transfer will not result in a change of the company's controlling shareholder or actual controller, nor will it trigger a mandatory bid or significantly impact the company's governance structure and ongoing operations [3][6].

证券日报网讯 1月9日，莱伯泰科发布公告称，2025年10月20日，公司持股5%以上股东 LabTechHoldings，Inc.（简称"LabTechHoldings"或"转让方"）与青岛市创新投资有限公司（简称"青岛 创新投资"或"受让方"）共同签署了《股份转让协议》，LabTechHoldings拟以27.50元/股的价格向青岛 创新投资转让其持有的公司无限售流通股4，145，454股，占公司股份总数的6.15%。本次协议转让完 成后，青岛创新投资将持有公司股份4，145，454股，占公司股份总数的6.15%，成为公司持股5%以上 股东。本次协议转让已取得上海证券交易所的合规性确认，并已取得中国证券登记结算有限责任公司出 具的《证券过户登记确认书》，过户日期为2026年1月8日，过户数量为4，145，454股（占公司股份总 数的6.15%），股份性质为无限售流通股，本次股份协议转让过户登记手续已办理完毕。 （文章来源：证券日报） ...

2025 年 10 月 20 日，北京莱伯泰科仪器股份有限公司（以下简称"莱伯 泰科"或"公司"）持股 5%以上股东 LabTech Holdings, Inc.（以下简称"LabTech Holdings"或"转让方"）与青岛市创新投资有限公司（以下简称"青岛创新投 资"或"受让方"）共同签署了《股份转让协议》，LabTech Holdings 拟以 27.50 元/股的价格向青岛创新投资转让其持有的公司无限售流通股 4,145,454 股，占 公司股份总数的 6.15%。本次协议转让完成后，青岛创新投资将持有公司股份 4,145,454 股，占公司股份总数的 6.15%，成为公司持股 5%以上股东。 本次协议转让已取得上海证券交易所的合规性确认，并已取得中国证券 登记结算有限责任公司出具的《证券过户登记确认书》，过户日期为 2026 年 1 月 8 日，过户数量为 4,145,454 股（占公司股份总数的 6.15%），股份性质为无 限售流通股。 本次协议转让受让方承诺在本次股份协议转让过户完成之日起 12 个月 内不减持其所受让的股份。 本次协议转让不会导致公司控股股东、实际控制人发生变更，不触及要 约 ...

Core Viewpoint - LabTech Holdings Inc. plans to transfer approximately 4.15 million shares of Beijing LabTech Instrument Co., Ltd. to Qingdao Innovation Investment Co., Ltd. at a price of 27.5 yuan per share, representing 6.15% of the company's total shares [1] Summary by Categories Share Transfer Agreement - The share transfer agreement was signed on October 20, 2025, between LabTech Holdings Inc. and Qingdao Innovation Investment Co., Ltd. [1] - The transfer price is set at 27.5 yuan per share for the 4.15 million shares being transferred [1] - The agreement has received compliance confirmation from the Shanghai Stock Exchange and a securities transfer registration confirmation from China Securities Depository and Clearing Corporation Limited [1] Share Details - The transferred shares are classified as unrestricted circulating shares [1] - The transfer date is scheduled for January 8, 2026, with the total number of shares representing 6.15% of the company's total shares [1]

Group 1 - The core viewpoint of the news is that Beijing Leibotai Technology Co., Ltd. has shown a slight increase in stock price, reaching 33.68 CNY per share, with a total market capitalization of 2.272 billion CNY as of December 31 [1] - The company specializes in the research, production, and sales of laboratory analytical instruments, with its main business revenue composition being 78.82% from analytical instruments, 12.57% from consumables and services, 7.88% from clean and environmentally friendly laboratory solutions, and 0.74% from other sources [1] - The company was established on January 8, 2002, and went public on September 2, 2020, indicating a relatively recent entry into the public market [1] Group 2 - Among the top circulating shareholders, Dazhong Fund's Dazhong Ruixiang Mixed A (008269) reduced its holdings by 114,200 shares in the third quarter, now holding 568,100 shares, which represents 0.84% of the circulating shares [2] - The Dazhong Ruixiang Mixed A fund has a current scale of 4.883 billion CNY and has achieved a year-to-date return of 12.01%, ranking 5512 out of 8085 in its category [2] - The fund manager, Xu Yan, has a tenure of 13 years and 65 days, with the fund's total asset size being 21.462 billion CNY, and the best return during his tenure being 152.72% [2]

Group 1 - The article highlights various job openings in the scientific instrument sales and support sectors, indicating a strong demand for skilled professionals in this industry [3][4][6][12][14][18][20]. - Positions range from sales engineers to product managers, with varying salary ranges, showcasing the competitive nature of the job market [6][12][14][18][20]. - Specific qualifications are emphasized, such as educational background in chemistry, biology, or engineering, along with relevant work experience and skills in communication and teamwork [5][7][8][13][19][21]. Group 2 - The article outlines the requirements for each position, including educational qualifications, years of experience, and specific technical skills needed for roles such as automation engineers and sales managers [11][15][22][25][29]. - Companies are looking for candidates who can adapt to frequent travel and possess strong problem-solving abilities, indicating the dynamic nature of the roles [7][10][17][32][35]. - The emphasis on teamwork and communication skills suggests that collaboration is crucial in these positions, reflecting the industry's focus on customer relations and service [13][21][22][34].

Group 1 - The core viewpoint of the article highlights that Laibotai Technology has been re-certified as a national-level "specialized and innovative" small giant enterprise, effective for another three years [1] - Laibotai Technology's revenue composition for the year 2024 is detailed, with other sectors accounting for 38.69%, environmental protection at 18.46%, medical testing at 6.91%, disease control at 6.79%, research institutions/universities at 6.61%, food and drug industry at 6.51%, geology/minerals/energy at 5.84%, and third-party testing at 5.6% [1] - The current market capitalization of Laibotai Technology is reported to be 2.4 billion yuan [2]

Core Points - The company, Beijing Leibotai Technology Co., Ltd., has been recognized as a national-level "specialized, refined, distinctive, and innovative" small giant enterprise for the fourth batch, with a validity period of three years [2] - The company has successfully passed the review and continues to hold the title of national-level "specialized, refined, distinctive, and innovative" small giant enterprise, as announced by the Beijing Municipal Bureau of Economy and Information Technology [2]

北京莱伯泰科仪器股份有限公司 关于公司国家级专精特新"小巨人" 复核通过的自愿性披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 基本情况 北京莱伯泰科仪器股份有限公司（以下简称"公司"）已于 2022 年被认定为 第四批国家级专精特新"小巨人"企业称号，有效期三年。 证券代码：688056 证券简称：莱伯泰科 公告编号：2025-038 1 三、 风险提示 公司本次通过国家级专精特新"小巨人"复核，不会对公司当期经营业绩产生 重大影响，敬请广大投资者谨慎投资，注意投资风险。 四、 备查文件 《北京市经济和信息化局关于北京市第七批专精特新"小巨人"企业和 2025 年专精特新"小巨人"复核通过企业名单进行公示的通知》 特此公告。 北京莱伯泰科仪器股份有限公司董事会 根据北京市经济和信息化局近日发布的《关于北京市第七批专精特新"小巨 人"企业和 2025 年专精特新"小巨人"复核通过企业名单进行公示的通知》，公司 已通过复核并继续被授予国家级专精特新"小巨人"企业称号，有效期三年。 二、 对公司的影响 国家级专 ...

Core Viewpoint - The company, 莱伯泰科, has successfully passed the national re-evaluation and continues to hold the title of "National Specialized and Innovative 'Little Giant' Enterprise" for another three years, reflecting government recognition of its innovation capabilities and market competitiveness [1] Group 1 - The company was recognized as a "Little Giant" enterprise in 2022, with the title valid for three years [1] - The recent announcement from the Beijing Economic and Information Technology Bureau confirms the company's re-evaluation and continued recognition [1] - This recognition enhances the company's visibility and market competitiveness, positively impacting its future development [1] Group 2 - The company aims to leverage this recognition to focus on its core business and innovation-driven development [1] - There is an emphasis on team building and market expansion to enhance core competitiveness and industry influence [1] - The goal is to become a leading and globally influential manufacturer in the instrumentation and meter industry [1]